1. Home
  2. APRE vs LMFA Comparison

APRE vs LMFA Comparison

Compare APRE & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • LMFA
  • Stock Information
  • Founded
  • APRE 2006
  • LMFA 2008
  • Country
  • APRE United States
  • LMFA United States
  • Employees
  • APRE N/A
  • LMFA N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • LMFA Finance: Consumer Services
  • Sector
  • APRE Health Care
  • LMFA Finance
  • Exchange
  • APRE Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • APRE 10.0M
  • LMFA 8.6M
  • IPO Year
  • APRE 2019
  • LMFA 2015
  • Fundamental
  • Price
  • APRE $1.71
  • LMFA $2.36
  • Analyst Decision
  • APRE Strong Buy
  • LMFA Hold
  • Analyst Count
  • APRE 2
  • LMFA 1
  • Target Price
  • APRE $15.50
  • LMFA N/A
  • AVG Volume (30 Days)
  • APRE 50.9K
  • LMFA 104.2K
  • Earning Date
  • APRE 08-11-2025
  • LMFA 08-13-2025
  • Dividend Yield
  • APRE N/A
  • LMFA N/A
  • EPS Growth
  • APRE N/A
  • LMFA N/A
  • EPS
  • APRE N/A
  • LMFA N/A
  • Revenue
  • APRE $1,284,475.00
  • LMFA $8,029,601.00
  • Revenue This Year
  • APRE N/A
  • LMFA $0.98
  • Revenue Next Year
  • APRE N/A
  • LMFA $4.31
  • P/E Ratio
  • APRE N/A
  • LMFA N/A
  • Revenue Growth
  • APRE 33.27
  • LMFA N/A
  • 52 Week Low
  • APRE $1.41
  • LMFA $1.02
  • 52 Week High
  • APRE $5.01
  • LMFA $5.35
  • Technical
  • Relative Strength Index (RSI)
  • APRE 52.34
  • LMFA 67.15
  • Support Level
  • APRE $1.48
  • LMFA $1.62
  • Resistance Level
  • APRE $1.91
  • LMFA $2.46
  • Average True Range (ATR)
  • APRE 0.16
  • LMFA 0.18
  • MACD
  • APRE -0.00
  • LMFA 0.05
  • Stochastic Oscillator
  • APRE 63.14
  • LMFA 82.74

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: